MAKAYLA HEISEY: Open Payments
NPI 1902501521 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 36 payments from 14 companies in 2025. Trend: 2023 $385 · 2024 $784 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $157 |
| ABBVIE INC. | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Amgen Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $40 |
| Lilly USA, LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Ozempic, TRINTELLIX, OTEZLA, VRAYLAR, REXULTI, Wegovy, BREZTRI, Rybelsus.
Industry payments across PA — which companies pay providers there.
